Last reviewed · How we verify

Extended Duration Combination NRT

University of Wisconsin, Madison · FDA-approved active Small molecule

Extended Duration Combination NRT delivers multiple forms of nicotine replacement therapy over a prolonged period to reduce withdrawal symptoms and support smoking cessation.

Extended Duration Combination NRT delivers multiple forms of nicotine replacement therapy over a prolonged period to reduce withdrawal symptoms and support smoking cessation. Used for Smoking cessation support.

At a glance

Generic nameExtended Duration Combination NRT
SponsorUniversity of Wisconsin, Madison
Drug classNicotine replacement therapy (combination)
TargetNicotinic acetylcholine receptors
ModalitySmall molecule
Therapeutic areaSmoking Cessation / Addiction Medicine
PhaseFDA-approved

Mechanism of action

This product combines different nicotine delivery modalities (such as patches, gum, or lozenges) designed to provide sustained nicotine replacement over an extended duration, addressing both the acute cravings and chronic withdrawal symptoms associated with smoking cessation. By maintaining more stable nicotine levels throughout the day and night, the combination approach aims to improve quit rates compared to single-modality NRT.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results